These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The role of aluminum in renal osteodystrophy. Sherrard DJ Mayo Clin Proc; 1993 May; 68(5):510-1. PubMed ID: 7683073 [No Abstract] [Full Text] [Related]
26. [The pathogenic mechanism, diagnosis and treatment of renal osteodystrophy]. Zhu JM Zhonghua Nei Ke Za Zhi; 1992 Jan; 31(1):49-51. PubMed ID: 1395914 [No Abstract] [Full Text] [Related]
27. Low turnover bone disease is the more common form of bone disease in CAPD patients. Rodriguez-Perez JC; Plaza C; Torres A; Vega N; Anabitarte A; Fernandez A; Lorenzo V; Hortal L; Palop L Adv Perit Dial; 1992; 8():376-80. PubMed ID: 1361827 [TBL] [Abstract][Full Text] [Related]
28. Uremic bone disease: current knowledge, controversial issues, and new horizons. Malluche HH; Monier-Faugere MC Miner Electrolyte Metab; 1991; 17(4):281-96. PubMed ID: 1813791 [TBL] [Abstract][Full Text] [Related]
30. Bone biopsy results and serum bone turnover parameters in uremic children. Ziólkowska H; Pańiczyk-Tomaszewska M; Debiński A; Polowiec Z; Sawicki A; Sieniawska M Acta Paediatr; 2000 Jun; 89(6):666-71. PubMed ID: 10914959 [TBL] [Abstract][Full Text] [Related]
31. Current status of the management of renal osteodystrophy. Fournier A; Sebert JL; Coevoet B; De Fremont JF; Hardin JM; Lambrey G Proc Eur Dial Transplant Assoc; 1978; 15():547-68. PubMed ID: 368790 [No Abstract] [Full Text] [Related]
32. [Role of aluminium and magnesium effects on initiation and promotion of renal osteodystrophy in patients with chronic renal failure]. Nakamrua M; Sato N; Tsukamoto Y; Marumo F; Iwanami S Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):421-8. PubMed ID: 3747253 [No Abstract] [Full Text] [Related]
33. Controlled study of renal osteodystrophy in patients undergoing dialysis. Pitts TO Am J Med; 1987 Dec; 83(6):1171-3. PubMed ID: 3332573 [No Abstract] [Full Text] [Related]
34. [Aluminum in renal osteodystrophy]. Zhu P; Wang GY; Yu YF; Zhu P Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):176-8. PubMed ID: 8222983 [TBL] [Abstract][Full Text] [Related]
35. Renal osteodystrophy. Coburn JW; Henry DA Adv Intern Med; 1984; 30():387-424. PubMed ID: 6397042 [TBL] [Abstract][Full Text] [Related]
36. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis. Coburn JW Kidney Int Suppl; 1993 Feb; 40():S92-100. PubMed ID: 8445845 [No Abstract] [Full Text] [Related]
37. Renal osteodystrophy. Parfitt AM Orthop Clin North Am; 1972 Nov; 3(3):681-98. PubMed ID: 4565585 [No Abstract] [Full Text] [Related]
38. [Current dilemmas and future perspectives in the treatment of renal osteodystrophy]. Fernández Giráldez E Nefrologia; 2000; 20 Suppl 3():41-51. PubMed ID: 10835876 [No Abstract] [Full Text] [Related]
39. New concepts in renal osteodystrophy. Hruska K Nephrol Dial Transplant; 1998 Nov; 13(11):2755-60. PubMed ID: 9829475 [No Abstract] [Full Text] [Related]
40. Bone disease in renal failure. Clinical and histomorphometric studies. Nilsson P Scand J Urol Nephrol Suppl; 1984; 84():1-68. PubMed ID: 6393322 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]